Antidiabetic treatment, achievement of fasting glucose <7 mmol/L in patients with psychotic disorders and control subjects with diabetes*
| Glucose levels | Patients with psychosis† | Control subjects | p Value |
|---|---|---|---|
| DM diagnosis | 94 (10.0)‡ | 69 (1.8) | 0.001§ |
| DM diagnosis and antidiabetic treatment | 40 (42.6) | 38 (55.1) | 0.114 |
| Metabolic syndrome | 33 (82.5) | ND | – |
| Fasting glucose <7.0 mmol/L | 13 (32.5) | 12 (31.6) | 0.931 |
| DM diagnosis and no antidiabetic treatment | 54 (57.4) | 31 (44.9) | 0.114 |
| Metabolic syndrome | 41 (77.4) | ND | – |
| Fasting glucose <7.0 mmol/L | 32 (59.3) | 18 (58.1) | 0.914 |
*Data reported as number (%). Among controls only participants who developed diabetes during the follow-up period are included.
†Number of patients varied due to sporadic missing information.
‡Two patients with psychosis with insulin treatment without DM diagnosis were included.
§p Value from logistic regression models controlling for differences in sex and age.
DM, diabetes mellitus; ND, not determined.